Among the notorious cancer-promoting Ras and Raf families of proteins, binding preferences matter.
Full story at National Cancer Institute
All in National Cancer Institute
Among the notorious cancer-promoting Ras and Raf families of proteins, binding preferences matter.
Full story at National Cancer Institute
Researchers manipulate a bacterial gene regulator to learn how to design RNA-targeted therapeutics.
Full story at National Cancer Institute
A massive DNA search brings viral dark matter into the light.
Full story at National Cancer Institute
Turning tumor-protecting immune cells into killers can strengthen the body’s fight against cancer.
Full story at National Cancer Institute
Microsatellite instability can disrupt long stretches of DNA and contort the genome into problematic shapes.
Full story at National Cancer Institute
The immune-modulating drug pomalidomide can be an effective treatment for chronic graft-versus-host disease.
Full story at National Cancer Institute
People with mutations in DNA repair genes may be more likely than others to develop small cell lung cancer.
Full story at National Cancer Institute
Embryonic stem cells call on genes typically used only during early development to protect vulnerable chromosome ends from unwanted DNA repair.
Full story at National Cancer Institute
NCI trial will evaluate the safety of metarrestin, a compound that laboratory studies suggest may stop the metastasis of many types of cancer.
Full story at National Cancer Institute